By Mariam Sunny and Christy Santhosh May 5 (Reuters) - Pfizer reported higher-than-expected sales and profit on Tuesday and ...

May 5 () - Pfizer on Tuesday ‌reported first-quarter ‌profit above Wall Street ​estimates, boosted by sustained demand for ...

Higher sales of cancer treatments helped fuel better-than-expected first-quarter sales and profit for the drugmaker.

Q1 2026 earnings call recap: revenue/EPS beat, 2026 guidance intact, Vyndamax & Comirnaty legal wins boost 2029+ outlook—read now.

The pharmaceutical company has been investing in its future growth, but whether its efforts will pay off is a big question ...

Pfizer’s Vyndamax will be free from generics competition until 2031 in a boost to the company’s revenue streams.

Pfizer Inc. (NYSE:PFE) is one of the best inexpensive stocks to buy now. On January 20, Novavax announced a non-exclusive licensing agreement with Pfizer, granting the pharmaceutical giant access to ...

NEW YORK, N.Y. — Pfizer announced Wednesday that data shows a third dose of its COVID-19 vaccine can “strongly” boost protection against the highly transmissible delta variant. The pharmaceutical and ...

Pfizer Inc. and Novo Nordisk A/S boosted their bids for obesity startup Metsera Inc. Novo’s updated offer values Metsera at a total of $10 billion, compared to the offer from Pfizer, which values the ...

May 5 (Reuters) - Pfizer posted better-than-expected quarterly earnings on Tuesday and said a recent favorable European court ...